Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Medtronic Aims To Double Its Presence In Emerging Markets By 2015-2016

This article was originally published in PharmAsia News

Executive Summary

In its first in-depth investor meeting in two years, Medtronic emphasized emerging markets, its ability to demonstrate economic worth, broad product offerings and pipeline as keys to growth.

You may also be interested in...

New Products In Brief

HeartWare ventricular assist device gains expanded labeling in Europe. Medigus gets 510(k) clearance for endoscopic GERD treatment. More new products.

Medtronic Partners With Payers To Prove Economic Worth

Recently inked partnerships with Aetna and a regional Italian government are focused on improving the economic data that Medtronic has at its disposal in support of its devices.

Research In Brief

New data on cardiac, diabetes and cancer testing.

Related Content


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts